1181. [Therapy-related myeloid neoplasms].1182. [Acute lymphoblastic leukemia (ALL)].1183. [Diagnosis and treatment of Waldenström macroglobulinemia].1184. [Molecular biology of myeloma].1185. [Pathogenesis and treatment of follicular lymphoma].1186. [Pathogenesis, pathophysiology and treatment of chronic lymphocytic leukemia].1187. [Prognostic factors in adult acute lymphoblastic leukemia].1188. [Pathology of acute lymphoblastic leukemia].1189. [Pathogenesis of acute promyelocytic leukemia].1190. [Prognostic factors of acute myeloid leukemia].1191. [Pathogenesis of acute myeloid leukemia].1192. [Pathogenesis, diagnosis and treatment of mastocytosis].1193. [Molecular pathogenesis and treatment of CML in accelerated phase and blast crisis].1195. [Genetic and cytogenetic abnormalities of multiple myeloma].1196. [Molecular pathogenesis of non-Hodgkin's lymphoma].1197. [Genome-wide analysis of AML and MDS].1198. [Genetic and cytogenetic abnormalities in leukemia].1199. [Proteasome oncology: pioneer a new field in drug development].1200. [Genomic instability in leukemia]. |